Clinical trial
Neurofibromatosis Type 1 (NF1) and Tibial Dysplasia
NCT00303368 · Shriners Hospitals for Children, Other · Completed
Key facts
| NCT number | NCT00303368 |
|---|---|
| Title | Neurofibromatosis Type 1 (NF1) and Tibial Dysplasia |
| Official title | Multicenter Study of Tibial Dysplasia in Neurofibromatosis Type I (NF1) Patients |
| Acronym | NF1TD |
| Lead sponsor | Shriners Hospitals for Children, Other |
| Collaborators | University of Utah |
| Status | Completed |
| Study type | Observational |
| Conditions | Neurofibromatosis Type 1, Tibial Dysplasia |
| Enrollment | 395 |
| Start date | Mar 1, 2004 |
| Primary completion | Jan 1, 2014 |
| Completion | Jan 1, 2016 |
| First posted | Mar 16, 2006 |
| Last update posted | Feb 25, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: